MedPath

Lung Ultrasound-guided Fluid Resuscitation in Neonatal Septic Shock

Not Applicable
Completed
Conditions
Septic Shock
Interventions
Diagnostic Test: lung ultrasound-guided fluid resuscitation
Registration Number
NCT06144463
Lead Sponsor
Guangdong Second Provincial General Hospital
Brief Summary

object name: Lung ultrasound-guided fluid resuscitation in neonatal septic shock.

type of study: prospective observational study. goal of study: The effects of severe ultrasound-assisted fluid resuscitation and conventional fluid resuscitation on the prognosis of children with neonatal septic shock were compared to evaluate the application value of the two techniques in fluid resuscitation of neonatal septic shock.

research design: In this study, children with neonatal septic shock diagnosed in the neonatal intensive care unit of the Second People 's Hospital of Guangdong Province from January 1,2022 to December 31,2023 were included in the population. According to the different monitoring methods used in conventional / clinical shock treatment, 30 cases of fluid resuscitation assisted by severe ultrasound, 30 cases of fluid resuscitation assisted by NICOM and 30 cases of conventional fluid resuscitation were collected, a total of 90 cases.

( 1 ) The demographic data, blood examination and microbiological examination data of the two groups at admission were collected.

( 2 ) The fluid volume, blood lactic acid, blood pressure, vasoactive drugs ( such as dopamine and epinephrine / norepinephrine ), mechanical ventilation, renal replacement therapy and antibiotic use were collected before fluid resuscitation.

( 3 ) The cumulative fluid infusion volume during fluid resuscitation ( 6 hours ), and the use of vasoactive drugs and mechanical ventilation for 6 hours were collected.

( 4 ) NICU hospitalization time, cumulative hospitalization time and mortality were collected.

Data collection :

( 1 ) The demographic data, blood examination and microbiological examination data of the three groups at admission were collected.

( 2 ) The fluid volume, blood lactic acid, blood pressure, vasoactive drugs ( such as dopamine and adrenaline / norepinephrine ), mechanical ventilation, renal replacement therapy and antibiotic use before fluid resuscitation were collected.

( 3 ) The cumulative fluid infusion volume during fluid resuscitation ( 6 hours ), and the use of vasoactive drugs and mechanical ventilation for 6 hours were collected.

( 4 ) NICU hospitalization time, cumulative hospitalization time and mortality were collected.

Detailed Description

Efficacy evaluation: The main efficacy criteria: NICU hospitalization time and cumulative hospitalization time, mortality. Secondary efficacy criteria: cumulative fluid volume during fluid resuscitation (6 hours), and use of vasoactive drugs and mechanical ventilation for 6 hours.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  1. Born less than 28 days on admission ;
  2. In line with the diagnostic criteria for neonatal septic shock in the ' 2020 International Guidelines for Saving Sepsis Campaign : Management of Sepsis-related Organ Dysfunction in Children ' ;
  3. For children diagnosed with septic shock, fluid resuscitation should be performed according to the routine diagnosis and treatment.
  4. The legal guardian has signed the informed consent.
Exclusion Criteria
  1. combined with neurogenic shock, trauma and hemorrhagic shock ;
  2. symptomatic patent ductus arteriosus ;
  3. combined with congenital heart disease ;
  4. give up treatment or death within 24 hours of admission ;
  5. The legal guardian refused to participate in the study ;
  6. Key information and information missing.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LUGFR grouplung ultrasound-guided fluid resuscitationlung ultrasound-guided fluid resuscitation
traditional grouplung ultrasound-guided fluid resuscitationNon-invasive cardiac output monitoring ( NICOM ) assisted fluid resuscitation.
Primary Outcome Measures
NameTimeMethod
hospitalization timeWithin 2 weeks

Primary indicator

mortalityWithin 2 weeks

Primary indicator

Secondary Outcome Measures
NameTimeMethod
Use of vasoactive drugsWithin 2 weeks

Secondary Outcome

Cumulative fluid volumeWithin 2 weeks

Secondary Outcome

Use of mechanical auxiliary gasWithin 2 weeks

Secondary Outcome

Trial Locations

Locations (1)

Guangdong Second Provincial General Hospital

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath